Details of the Drug

General Information of Drug (ID: DMZ1CJL)

Drug Name

KRL-401

Indication

Disease Entry	ICD 11	Status	REF
Attention deficit hyperactivity disorder	6A05.Z	Phase 1	[1]
------------------------------------------------------------------------------------

Cross-matching ID

References

1	Pharmaceutical Research Companies Are Developing Nearly 200 Medicines to Treat Mental Illnesses and Addictive Disorders. Pharmaceutical Research and Manufacturers of America report. 2012.